rs66844808

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000231.3(SGCG):​c.386-30A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 1,603,962 control chromosomes in the GnomAD database, including 11,480 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 975 hom., cov: 32)
Exomes 𝑓: 0.11 ( 10505 hom. )

Consequence

SGCG
NM_000231.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.123
Variant links:
Genes affected
SGCG (HGNC:10809): (sarcoglycan gamma) This gene encodes gamma-sarcoglycan, one of several sarcolemmal transmembrane glycoproteins that interact with dystrophin. The dystrophin-glycoprotein complex (DGC) spans the sarcolemma and is comprised of dystrophin, syntrophin, alpha- and beta-dystroglycans and sarcoglycans. The DGC provides a structural link between the subsarcolemmal cytoskeleton and the extracellular matrix of muscle cells. Defects in the encoded protein can lead to early onset autosomal recessive muscular dystrophy, in particular limb-girdle muscular dystrophy, type 2C (LGMD2C). [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 13-23279329-A-G is Benign according to our data. Variant chr13-23279329-A-G is described in ClinVar as [Benign]. Clinvar id is 255601.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-23279329-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.122 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SGCGNM_000231.3 linkuse as main transcriptc.386-30A>G intron_variant ENST00000218867.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SGCGENST00000218867.4 linkuse as main transcriptc.386-30A>G intron_variant 1 NM_000231.3 P1

Frequencies

GnomAD3 genomes
AF:
0.106
AC:
16047
AN:
152024
Hom.:
973
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0842
Gnomad AMI
AF:
0.227
Gnomad AMR
AF:
0.101
Gnomad ASJ
AF:
0.159
Gnomad EAS
AF:
0.000772
Gnomad SAS
AF:
0.0369
Gnomad FIN
AF:
0.124
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.125
Gnomad OTH
AF:
0.119
GnomAD3 exomes
AF:
0.0962
AC:
24134
AN:
250788
Hom.:
1415
AF XY:
0.0967
AC XY:
13112
AN XY:
135586
show subpopulations
Gnomad AFR exome
AF:
0.0808
Gnomad AMR exome
AF:
0.0778
Gnomad ASJ exome
AF:
0.158
Gnomad EAS exome
AF:
0.000272
Gnomad SAS exome
AF:
0.0410
Gnomad FIN exome
AF:
0.120
Gnomad NFE exome
AF:
0.124
Gnomad OTH exome
AF:
0.113
GnomAD4 exome
AF:
0.115
AC:
166690
AN:
1451820
Hom.:
10505
Cov.:
30
AF XY:
0.113
AC XY:
81649
AN XY:
722494
show subpopulations
Gnomad4 AFR exome
AF:
0.0798
Gnomad4 AMR exome
AF:
0.0804
Gnomad4 ASJ exome
AF:
0.155
Gnomad4 EAS exome
AF:
0.000431
Gnomad4 SAS exome
AF:
0.0431
Gnomad4 FIN exome
AF:
0.116
Gnomad4 NFE exome
AF:
0.126
Gnomad4 OTH exome
AF:
0.112
GnomAD4 genome
AF:
0.106
AC:
16059
AN:
152142
Hom.:
975
Cov.:
32
AF XY:
0.104
AC XY:
7760
AN XY:
74384
show subpopulations
Gnomad4 AFR
AF:
0.0844
Gnomad4 AMR
AF:
0.101
Gnomad4 ASJ
AF:
0.159
Gnomad4 EAS
AF:
0.000774
Gnomad4 SAS
AF:
0.0371
Gnomad4 FIN
AF:
0.124
Gnomad4 NFE
AF:
0.125
Gnomad4 OTH
AF:
0.119
Alfa
AF:
0.119
Hom.:
199
Bravo
AF:
0.104
Asia WGS
AF:
0.0280
AC:
100
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Autosomal recessive limb-girdle muscular dystrophy type 2C Benign:1
Benign, criteria provided, single submitterclinical testingPars Genome LabJul 01, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 14, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.2
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs66844808; hg19: chr13-23853468; API